发明名称 CCN3 AND CCN3 PEPTIDES AND ANALOGS THEREOF FOR THERAPEUTIC USE
摘要 The present invention provides a method for treating a human patient with a pathology by administering to the subject an effective amount of an agent selected from the group of: native full-length CCN3 proteins; analog CCN3 full-length proteins with native cysteine residues substituted by a replacement amino acid; CCNp native peptide fragments having from about 12 to about 20 amino acids; analog CCNp peptide fragments with native cysteine residues substituted with a replacement amino acid; and combinations thereof.
申请公布号 US2015337020(A1) 申请公布日期 2015.11.26
申请号 US201514821494 申请日期 2015.08.07
申请人 Rosalind Franklin University of Medicine and Science 发明人 Riser Bruce L.
分类号 C07K14/47;A61K35/12;A61K38/17;A61K9/00 主分类号 C07K14/47
代理机构 代理人
主权项 1. A method for preventing and or treating fatty liver disease, steatosis, liver fibrosis, and liver cancer in a subject in need thereof comprising: administering to the subject an effective amount of a native CCNp38 peptide fragment (SEQ. ID. Nos. 49, 50) or an analog CCNp38 peptide fragment with native cysteine residues substituted with a replacement amino acid (SEQ. ID. Nos. 38, 56, 57, 58, and 60).
地址 North Chicago IL US